Upside – $MEDS +36% (preliminary September pharmacy revenue exceeded $1M, rising more than 66% from July) – $ACN +17% (Q4 beat with $22.2B of bookings and stronger operating margins) – $ABAT +13% (receives federal approval to export up to $100M of recycled black-mass material) – $QSI +13% (no clear fresh catalyst identified; unusually large move …
Read in context ›McCormick & Company Stock (MKC)
Track McCormick & Company stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
MKC
McCormick & Company
consumerdefensive
At close
$45.54
▲ +0.87 (+1.95%)
Oct 5, 4:00 PM ET
After-hours
$45.69
▲ +0.15 (+0.33%)
Oct 5, 4:18 PM ET
Market Cap
$12.03B
P/E Ratio
8.1x
1Y Return
-32.28%
EPS (TTM)
$5.53
Read the latest TheStreet Pro articles mentioning McCormick & Company, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
27 articlesDaily Diary Mentions
1 mentionUpside, Downside Movers in the Morning